InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Wave Life Sciences, Inc.

WVE Clue Score51
United States Fiscal year ends December CIK 0001631574 Results filed 27 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
30 Mar 2026
Director
Buy indirect
971,091
$6.50
$6.31M
Ra Capital Management, L.p.
27 Mar 2026
Director
Buy indirect
2,495,623
$6.43
$16.05M
Ra Capital Management, L.p.
26 Mar 2026
Director
Buy indirect
351,224
$6.38
$2.24M
Ra Capital Management, L.p.
26 Mar 2026
Director
Buy indirect
4,954,558
$6.06
$30.02M
GSK plc
11 Dec 2025
10% owner
Buy indirect
1,470,000
$19.00
$27.93M
Ra Capital Management, L.p.
13 Nov 2025
Director
Buy indirect
1,000
$6.69
$6.69K
GSK plc
27 Sep 2024
10% owner
Buy indirect
2,791,930
$8.00
$22.34M
Ra Capital Management, L.p.
11 Dec 2023
Director
Buy indirect
1,000,000
$5.00
$5.00M
GSK plc
7 Dec 2023
10% owner
Buy indirect
3,300,000
$5.00
$16.50M
Ra Capital Management, L.p.
16 Jun 2022
Director
Buy indirect
9,480,052
$2.15
$20.38M
Ra Capital Management, L.p.
24 Jan 2019
Director
Buy indirect
263,158
$38.00
$10.00M
Ra Capital Management, L.p.
14 Nov 2017
Director
Buy indirect
23,398
$24.00
$561.55K
Ra Capital Management, L.p.
13 Nov 2017
Director
Buy indirect
400,000
$23.30
$9.32M
Show all 166 transactions →

What was left out

Form 4 filings counted 234
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 74
Sales at will 50
Transactions with no price 0
Shares from compensation/vesting 9,171,525
Sales filed before the plan box existed 46
History held since 18 Nov 2015